MoneyWorks4Me

Indoco Remedies informs about annual report

26 Aug 2022 Evaluate

Pursuant to Regulation 34(1) of Securities Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015 (‘SEBI Listing Regulations’), Indoco Remedies has submitted the Annual Report of the Company along with the Notice of AGM for the financial year 2021-2022. The annual report containing the notice of AGM will be made available on Company’s website, at www.indoco.com.

The above information is a part of company’s filings submitted to BSE.

Peers
Company Name CMP
Sun Pharma. Inds. 1756.90
Dr. Reddys Labs. 1195.10
Cipla 1303.30
Lupin 1960.00
Zydus Lifesciences 1115.10
View more..